NCT00862264View on ClinicalTrials.gov

Efficacy and Tolerability of Beclomethasone Dipropionate/Formoterol Single Inhaler in Patients With Mild to Moderate Persistent Asthma

PHASE3CompletedINTERVENTIONAL

Enrollment

286

Participants

Timeline

Start Date

August 31, 2004

Study Completion Date

September 30, 2005

Conditions

Asthma

Interventions

DRUG

Fixed combination Beclomethasone Dipropionate/Formoterol HFA 134a-pMDI

All Listed Sponsors

lead

Chiesi Farmaceutici S.p.A.

INDUSTRY

NCT00862264 - Efficacy and Tolerability of Beclomethasone Dipropionate/Formoterol Single Inhaler in Patients With Mild to Moderate Persistent Asthma | Biotech Hunter | Biotech Hunter